Valeris Secures Removal of Client Brands from SaveOn SP Copay Maximizer Program
Event summary
- Valeris removed several client brands from the SaveOn SP copay maximizer drug list on July 27, 2026.
- The removal restores full copay assistance value for patients and manufacturer partners.
- Valeris' Patient Affordability team employed sustained mitigation efforts to achieve this outcome.
- Copay maximizer programs now affect a majority of commercially insured lives in the U.S.
The big picture
Valeris' victory against SaveOn SP's copay maximizer program highlights the growing tension between manufacturer assistance programs and payer tactics. The removal of client brands from the maximizer list restores intended benefits for patients and partners, but the broader trend of expanding maximizer adoption suggests ongoing challenges in the commercial insurance market.
What we're watching
- Maximizer Expansion
- The pace at which copay maximizer adoption continues to grow across commercial insurance markets.
- Mitigation Effectiveness
- Whether Valeris' proactive monitoring and advocacy can sustain similar wins for other client brands.
- Industry Response
- How manufacturers and payers react to Valeris' success in challenging maximizer programs.
Related topics